" /> rituximab-alliinase conjugate - CISMeF





Preferred Label : rituximab-alliinase conjugate;

MeSH note : alliinase conjugated to the monoclonal antibody rituximab, which recognizes the CD20 antigen, and the resulting conjugate was targeted to CD20 B chronic lymphocytic leukemia (B-CLL) and other B-cell lymphomas;

Is substance : O;

Détails


Vous pouvez consulter :


Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.